Cisplatin

BCL2 apoptosis regulator ; Homo sapiens







433 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
401 11774739 Mitochondria in platinum resistant cells. 2001 Sep 2
402 10601800 Regulation of apoptosis reduction in the cisplatin-resistant A431 cell line by Bcl-2 and CPP32. 2000 Jan-Feb 2
403 10646901 BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. 2000 Jan 2
404 10731694 Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. 2000 Feb 1
405 10807947 Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. 2000 Jul 1 1
406 10891529 Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene. 2000 Aug 5
407 11040047 G(1) phase-dependent expression of bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells. 2000 Nov 2
408 11775848 Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells. 2000 Oct 5
409 11778475 [Bcl-2 antisense oligodeoxyribonucleotide increases apoptosis of lung carcinoma cells induced by cisplatin]. 2000 Dec 3
410 10063313 The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells. 1999 Jan 2
411 10067009 Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell lines. 1999 Feb 2
412 10344753 Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. 1999 May 15 1
413 10397248 Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines. 1999 Jul 1 1
414 10569615 Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2. 1999 Dec 7
415 10597253 The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells. 1999 Nov 11 1
416 10615232 Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer. 1999 Aug 2
417 11776616 [Expression and reversion of drug resistance- and apoptosis-related genes of a DDP-resistant lung adenocarcinoma cell line A549DDP]. 1999 Nov 1
418 9472640 Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts. 1998 2
419 9484785 Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. 1998 Feb 19 1
420 9584207 Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. 1998 May 1
421 9635829 Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. 1998 May 1
422 9664115 The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells. 1998 Aug 1
423 9792147 Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines. 1998 Oct 1
424 10081494 EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway. 1998 Dec 1
425 9323493 Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-induced apoptosis. 1997 4
426 9393748 Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. 1997 Dec 1 1
427 9403032 Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. 1997 Nov 19 1
428 9494534 Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. 1997 Nov-Dec 1
429 9815594 all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells. 1997 Nov 1
430 8616869 The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. 1996 May 1 3
431 7539458 Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. 1995 Jun 1
432 8205548 Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. 1994 Jun 15 1
433 21573386 Functional similarity between adenovirus e1b 19k gene and bcl2 oncogene - mutant complementation and suppression of cell-death induced by DNA-damaging agents. 1993 Sep 1